Found 30 matching trials
Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma PHASE2 This phase II trial studies how well dabrafenib, trametinib, and spartalizu...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Reducing Symptom Burden Through Physical Exercise in Melanoma Patients NA The aim of the clinical trial is to determine whether regular exercise can ...
Show More Location
University Hospital Essen
Learn More & Join Trial
Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis N/A This multicenter, retrospective observational study aims to identify clinic...
Show More Location
Ankara Etlik City Hospital
Learn More & Join Trial
A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors PHASE2 This study is aim to evaluate the preliminary efficacy of GH21 combined wit...
Show More Location
Cancer Hospital Chinese Academy of Medical Science
Learn More & Join Trial
SMMART Adaptive Clinical Treatment (ACT) Trial EARLY_PHASE1 SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy PHASE2 This pilot phase 2 study evaluates the effectiveness and safety of the Rech...
Show More Location
Saint Petersburg State University Hospital
Learn More & Join Trial
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics NA This a prospective real-world navigation study using tumor DNA sequencing t...
Show More Status
Active Not Recruiting
Location
Peking University Cancer Hospital
Learn More & Join Trial
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic PHASE2 This phase II trial studies how well molecularly targeted therapy works in ...
Show More Location
Mayo Clinic Cancer Center
Learn More & Join Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) PHASE2 This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations PHASE2 This BVD-523-ABC study builds on the safety and clinical activity experienc...
Show More Learn More & Join Trial